Toboroz
A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
NCT07584967· 2. fázis· AnaCardio AB· Forrás
Még nem toboroz
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
NCT07873801· 3. fázis· Almirall, S.A.· Forrás
Még nem toboroz
A trial to learn how well AZD0120 works and about its safety in adults with transplant eligible newly diagnosed multiple myeloma.
2026-525367-40-00· 3. fázis· AstraZeneca AB· Forrás
Toboroz
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
NCT07919678· 3. fázis· Pfizer· Forrás
Még nem toboroz
A phase II clinical trial of neoadjuvant treatment with Ivonescimab and chemotherapy for stage IIA-IIB-IIIA and IIIB (T3N2) non-small cell lung cancer (NSCLC) patients
2026-525303-27-00· 2. fázis· Fundacion GECP· Forrás
Még nem toboroz
Multicenter, open label, phase II clinical trial evaluating the combination of elranatamab with mezigdomide and dexamethasone in patients with relapsed/refractory multiple myeloma
2026-526352-31-00· 2. fázis· Fundacion PETHEMA· Forrás
Toboroz
A study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
2025-524915-36-00· 1/2. fázis· Glaxosmithkline Research & Development Limited· Forrás
Toboroz
A Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
2026-526654-14-01· 3. fázis· Janssen Cilag International· Forrás
Még nem toboroz
A phase II clinical trial of inotuzumab ozogamicin as prophylaxis for relapse in patients with lymphoblastic leukaemia after allogeneic stem cell haemotopoietic transplantation
2026-525964-17-00· 2. fázis· Fundacion PETHEMA· Forrás
Toboroz
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161· 3. fázis· Takeda· Forrás
Még nem toboroz
A Phase 1 Study of TT125-802 as Monotherapy and in Combination with Pomalidomide
and Dexamethasone in Participants with Multiple Myeloma
2025-523536-39-00· 1. fázis· TOLREMO therapeutics AG· Forrás
Még nem toboroz
Study of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
2025-524606-15-00· 3. fázis· Tecnimede-Sociedade Tecnico-Medicinal S.A.· Forrás
Toboroz
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117· 3. fázis· AstraZeneca· Forrás
Toboroz
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
NCT07775300· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with
Relapsed or Refractory Multiple Myeloma
2025-523815-12-00· 3. fázis· Janssen Cilag International· Forrás
Toboroz
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
NCT07695701· 4. fázis· Eidos Therapeutics, a BridgeBio company· Forrás
Toboroz
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
NCT07634471· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
NCT07277387· Instituto de Investigación Biomédica de Salamanca· Forrás
Még nem toboroz
A trial to learn how well AZD0120 works and about its safety in adults with newly diagnosed multiple myeloma
2025-524014-29-00· 3. fázis· AstraZeneca AB· Forrás
Toboroz
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
NCT07429266· 3. fázis· Ono Pharmaceutical Co., Ltd.· Forrás
Toboroz
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
NCT07393282· 3. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás
Toboroz
Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke
NCT07113184· Instituto de Investigación Marqués de Valdecilla· Forrás
Toboroz
Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial
NCT07015892· 3. fázis· Instituto de Investigación Biomédica de Salamanca· Forrás
Toboroz
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
NCT07484009· Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal· Forrás
Toboroz
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás
Toboroz
Using Advanced CT Scans and Blood Markers to Better Understand Heart Damage and Recovery After a Heart Attack
NCT07268391· Instituto de Investigación Biomédica de Salamanca· Forrás
Toboroz
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752· 3. fázis· Novartis Pharmaceuticals· Forrás
Még nem toboroz
Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia
NCT06830733· 2. fázis· Fundacion Clinic per a la Recerca Biomédica· Forrás
Toboroz
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
NCT06697184· 1/2. fázis· BeOne Medicines· Forrás
Toboroz
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
NCT06724159· Spanish Oncology Genito-Urinary Group· Forrás
Toboroz
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
NCT06919341· Fundación Española de Hematología y Hemoterapía· Forrás
Fut, nem toboroz
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol After Gastric Surgery (POWER 4 + 3)
NCT06790238· Grupo Español de Rehabilitación Multimodal· Forrás
Toboroz
PulseSelect™ PFA Global Registry
NCT06393920· Medtronic Cardiac Ablation Solutions· Forrás
Fut, nem toboroz
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
NCT06402838· 2. fázis· Hoffmann-La Roche· Forrás
Toboroz
Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)
NCT06379945· Instituto de Investigación Biomédica de Salamanca· Forrás
Toboroz
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment
NCT06439173· Instituto de Investigación Biomédica de Salamanca· Forrás
Fut, nem toboroz
A Study of Daratumumab
NCT05438043· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
NCT05511363· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás
Fut, nem toboroz
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755· Medtronic Cardiovascular· Forrás
Fut, nem toboroz
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT05152147· 3. fázis· Jazz Pharmaceuticals· Forrás
Fut, nem toboroz
Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk
NCT04829929· Eclipse Medical Ltd.· Forrás
Toboroz
Spanish Registry of Esophagogastric Cancer
NCT04958720· Fundación Sociedad Española de Oncologia Médica· Forrás
Toboroz
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NCT03711110· Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León· Forrás
Fut, nem toboroz
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
NCT03595592· 3. fázis· Fondazione Michelangelo· Forrás
Fut, nem toboroz
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771· Grupo Español Multidisciplinar de Melanoma· Forrás